Epizyme, Inc.

NasdaqGS:EPZM Rapport sur les actions

Capitalisation boursière : US$247.5m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Epizyme Bilan de santé

Santé financière contrôle des critères 0/6

Informations clés

-1,148.4%

Ratio d'endettement

US$232.91m

Dette

Ratio de couverture des intérêtsn/a
Argent liquideUS$144.41m
Fonds propres-US$20.28m
Total du passifUS$284.44m
Total des actifsUS$264.16m

Mises à jour récentes de la santé financière

Recent updates

Epizyme GAAP EPS of -$0.21, revenue of $27.5M

Aug 09

Epizyme Acquisition By Ipsen: CVR Value

Jul 05

Some Epizyme, Inc. (NASDAQ:EPZM) Analysts Just Made A Major Cut To Next Year's Estimates

May 16
Some Epizyme, Inc. (NASDAQ:EPZM) Analysts Just Made A Major Cut To Next Year's Estimates

Epizyme: Taking Advantage Of Recent Sell-Off

Nov 25

Health Check: How Prudently Does Epizyme (NASDAQ:EPZM) Use Debt?

Sep 14
Health Check: How Prudently Does Epizyme (NASDAQ:EPZM) Use Debt?

Industry Analysts Just Made A Sizeable Upgrade To Their Epizyme, Inc. (NASDAQ:EPZM) Revenue Forecasts

Aug 10
Industry Analysts Just Made A Sizeable Upgrade To Their Epizyme, Inc. (NASDAQ:EPZM) Revenue Forecasts

Epizyme: Potential Comeback With Tazemetostat After Initial Sales Challenge

Jun 22

Is Epizyme (NASDAQ:EPZM) Using Too Much Debt?

Jun 08
Is Epizyme (NASDAQ:EPZM) Using Too Much Debt?

Epizyme gains as peer Constellation attracts sizable premium from MorphoSys

Jun 02

Epizyme, Inc. 2021 Q1 - Results - Earnings Call Presentation

May 07

Epizyme, Inc. (NASDAQ:EPZM) Analysts Just Trimmed Their Revenue Forecasts By 41%

Feb 25
Epizyme, Inc. (NASDAQ:EPZM) Analysts Just Trimmed Their Revenue Forecasts By 41%

Is Epizyme (NASDAQ:EPZM) Using Too Much Debt?

Jan 16
Is Epizyme (NASDAQ:EPZM) Using Too Much Debt?

Epizyme says Boehringer terminates collaboration agreement

Dec 24

Would Shareholders Who Purchased Epizyme's (NASDAQ:EPZM) Stock Year Be Happy With The Share price Today?

Dec 12
Would Shareholders Who Purchased Epizyme's (NASDAQ:EPZM) Stock Year Be Happy With The Share price Today?

Epizyme Q3 2020 Earnings Preview

Nov 05

Analyse de la situation financière

Passif à court terme: EPZM has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Passif à long terme: EPZM has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Historique et analyse du ratio d'endettement

Niveau d'endettement: EPZM has negative shareholder equity, which is a more serious situation than a high debt level.

Réduire la dette: EPZM's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilan


Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: EPZM has less than a year of cash runway based on its current free cash flow.

Prévisions de trésorerie: EPZM has less than a year of cash runway if free cash flow continues to reduce at historical rates of 17.8% each year


Découvrir des entreprises saines